Terms: = Lung cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Staging
33 results:
1. Development and validation of a prognostic nomogram for patients with laryngeal cancer with synchronous or metachronous lung cancer.
Su H; Li H; Hou S; Song X; Zhang X; Wang W; Li Z
Head Neck; 2024 Jan; 46(1):177-191. PubMed ID: 37930037
[TBL] [Abstract] [Full Text] [Related]
2. The International Association for the Study of lung cancer Pleural Mesothelioma staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract] [Full Text] [Related]
3. Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study.
Wang L; Peng JL; Wu JZ
Medicine (Baltimore); 2023 Mar; 102(13):e33319. PubMed ID: 37000113
[TBL] [Abstract] [Full Text] [Related]
4. Classification of Histological Types and Stages in Non-small Cell lung cancer Using Radiomic Features Based on CT Images.
Lin J; Yu Y; Zhang X; Wang Z; Li S
J Digit Imaging; 2023 Jun; 36(3):1029-1037. PubMed ID: 36828962
[TBL] [Abstract] [Full Text] [Related]
5. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
[TBL] [Abstract] [Full Text] [Related]
6. Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma.
Yeap BY; De Rienzo A; Gill RR; Oster ME; Dao MN; Dao NT; Levy RD; Vermilya K; Gustafson CE; Ovsak G; Richards WG; Bueno R
J Thorac Oncol; 2021 Nov; 16(11):1925-1935. PubMed ID: 34242791
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell lung cancer.
Tsutani Y; Imai K; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
Ann Thorac Surg; 2022 May; 113(5):1608-1616. PubMed ID: 34186090
[TBL] [Abstract] [Full Text] [Related]
8. Surgical Prognosis of Synchronous Multiple Primary lung cancer: Systematic Review and Meta-Analysis.
Nie Y; Wang X; Yang F; Zhou Z; Wang J; Chen K
Clin Lung Cancer; 2021 Jul; 22(4):341-350.e3. PubMed ID: 33243621
[TBL] [Abstract] [Full Text] [Related]
9. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.
Papageorgiou I; Dvorak J; Cosma I; Pfeil A; Teichgraeber U; Malich A
Clin Transl Oncol; 2020 Aug; 22(8):1321-1328. PubMed ID: 31858434
[TBL] [Abstract] [Full Text] [Related]
10. Multi-technique imaging of bone metastases: spotlight on PET-CT.
Azad GK; Cook GJ
Clin Radiol; 2016 Jul; 71(7):620-31. PubMed ID: 26997430
[TBL] [Abstract] [Full Text] [Related]
11. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell lung cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract] [Full Text] [Related]
12. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract] [Full Text] [Related]
13. Meta-Analysis of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells as Prognostic Factors in lung cancer.
Yu M; Men HT; Niu ZM; Zhu YX; Tan BX; Li LH; Jiang J
Asian Pac J Cancer Prev; 2015; 16(14):6123-8. PubMed ID: 26320506
[TBL] [Abstract] [Full Text] [Related]
14. Appropriateness of imaging for lung cancer staging in a national cohort.
Backhus LM; Farjah F; Varghese TK; Cheng AM; Zhou XH; Wood DE; Kessler L; Zeliadt SB
J Clin Oncol; 2014 Oct; 32(30):3428-35. PubMed ID: 25245440
[TBL] [Abstract] [Full Text] [Related]
15. Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.
Chen X; Sun L; Cong Y; Zhang T; Lin Q; Meng Q; Pang H; Zhao Y; Li Y; Cai L; Dong X
J Exp Clin Cancer Res; 2014 Mar; 33(1):28. PubMed ID: 24628817
[TBL] [Abstract] [Full Text] [Related]
16. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
Sim YT; Goh YG; Dempsey MF; Han S; Poon FW
Lung; 2013 Dec; 191(6):625-32. PubMed ID: 24013495
[TBL] [Abstract] [Full Text] [Related]
17. Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.
Fuccio C; Castellucci P; Schiavina R; Guidalotti PL; Gavaruzzi G; Montini GC; Nanni C; Marzola MC; Rubello D; Fanti S
Eur J Radiol; 2012 Aug; 81(8):e893-6. PubMed ID: 22621862
[TBL] [Abstract] [Full Text] [Related]
18. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
[TBL] [Abstract] [Full Text] [Related]
19. [Complete resection of an advanced mediastinal nonseminomatous germ cell tumor with multiple distant metastases after down-staging by chemotherapy].
Usuda K; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Tsuchihara K; Masaki Y; Kinoshita E; Sakuma T
Kyobu Geka; 2009 Jul; 62(7):545-51. PubMed ID: 19588824
[TBL] [Abstract] [Full Text] [Related]
20. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
Krüger S; Buck AK; Mottaghy FM; Hasenkamp E; Pauls S; Schumann C; Wibmer T; Merk T; Hombach V; Reske SN
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1807-12. PubMed ID: 19504092
[TBL] [Abstract] [Full Text] [Related]
[Next]
